Web13 apr. 2024 · INZY Inozyme Pharma, Inc. Earnings Date & History 788 followers ( +14.89% 3:59 PM 04/06/23 NASDAQ $USD Pre-Market: $5.68 +0.01 (+0.18%) 6:37 … WebFind the latest Earnings Report Date for Inozyme Pharma, Inc. Common Stock (INZY) at Nasdaq.com. Inozyme Pharma, Inc. Common Stock (INZY) Earnings Report Date …
Inozyme Pharma (INZY) Earnings Date & Reports - TipRanks
Web22 mrt. 2024 · INZY has generated -$2.26 earnings per share over the last four quarters. What is Inozyme Pharma's EPS forecast for next year? Inozyme Pharma's earnings are … Web14 apr. 2024 · RenovoRx (NASDAQ:RNXT – Get Rating) and Inozyme Pharma (NASDAQ:INZY – Get Rating) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, profitability, dividends, valuation, analyst recommendations, institutional ownership and … iproute2alam recipe veenas curryworld
INZY Earnings Date 2024 Inozyme Pharma Earnings Forecast
Web12 apr. 2024 · Check if INZY Stock has a Buy or Sell Evaluation. INZY Stock Price (NASDAQ), Forecast, Predictions, ... The upcoming earnings date for Inozyme Pharma, Inc. is 2024-05-09 00:00:00. Click to get the best stock tips daily for … WebOn Invalid Date, Inozyme Pharma (NASDAQ: INZY) reported Q4 2024 earnings per share (EPS) of -$0.42, up 46.84% year over year. Total Inozyme Pharma earnings for the quarter were -$18.54 million. In the same quarter last year, Inozyme Pharma's earnings per share (EPS) was -$0.79. Web13 apr. 2024 · We are developing INZ-701, an enzyme therapy, to address pathologic mineralization and intimal proliferation which can drive morbidity and mortality in these severe diseases. INZ-701 is currently in Phase 1/2 clinical trials for the treatment of ENPP1 Deficiency and ABCC6 Deficiency. View Corporate Presentation Stock Quote Change iprov230win_web.exe